SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Sofimed
Sofimed Spółka z Ograniczoną Odpowiedzialnością w Likwidacji
Wyniki finansowe firmy Sofimed: przychody, zysk netto, rentowność, ROE, marża, wskaźniki inwestorskie i wycena. Dane z oficjalnych sprawozdań KRS (0000351905).
Sofimed has filed financial statements for 6 reporting years in the Polish National Court Register (KRS 0000351905), covering 2018–2023. The dashboard below shows the income statement, balance sheet, profitability ratios, valuation indicators and a multi-year comparison against the company's industry benchmark.
Headline figures for the most recent reported year (2023): net revenue 1,544,042 PLN, net profit 57,678 PLN, total assets 163,133 PLN and equity 95,478 PLN. Use the chart toolbar to switch between absolute amounts and indexed series, or to jump straight into the per-year sprawozdanie finansowe.
Derived metrics include ROE, ROA, net and operating margin, the current ratio and the cash ratio, debt-to-equity and asset turnover. Each ratio is plotted alongside the median for Sofimed's PKD activity class, so reading whether the company is above or below the industry takes one glance instead of a side-by-side calculation.
Revenue
1.5 M PLN
2023
Net profit
57.7 K PLN
2023
Assets
163.1 K PLN
2023
Equity
95.5 K PLN
2023
EBITDA
110.5 K PLN
2023
Valuation
0 PLN
closed
Analysis of financial data across available reporting years
ROA
35.36%
Positive return on assets
Debt ratio
0.41
Balanced leverage
Asset turnover
9.46
Net margin
3.74%
ROE
60.41%
Current ratio
1.41
Gross margin
3.74%
Operating margin
4.12%
Debt / equity
0.71
Working capital
27.5 K PLN
6 years of data (2018–2023)
Revenue
2023
Net profit
4/6 profitable years
Assets
2023
Equity
2023
Net revenue
Net profit / loss
Profit waterfall 2023
Cost structure 2023
Ratios 2023
Full table of ratios over 6 years (2018–2023)
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 0.67% | 2.89% | 4.41% | -2.93% | 3.74% |
| Operating margin | -2.63% | 3.30% | 4.73% | -2.46% | 4.12% |
| EBIT margin | -2.63% | 3.30% | 4.73% | -2.46% | 4.12% |
| EBITDA margin | 0.75% | 6.74% | 7.75% | 0.45% | 7.16% |
| Net margin | 0.00% | 2.89% | 4.17% | -2.93% | 3.74% |
| ROA | 0.00% | 12.81% | 17.39% | -38.55% | 35.36% |
| ROE | 0.00% | 31.02% | 30.54% | -125.40% | 60.41% |
| Liquidity | |||||
| Current ratio | 2.32 | 0.83 | 1.28 | 0.52 | 1.41 |
| Cash ratio | 0.88 | 0.71 | 1.18 | 0.41 | 1.22 |
| Working capital | 156.2 K PLN | -38.1 K PLN | 46.7 K PLN | -40.5 K PLN | 27.5 K PLN |
| Working capital / revenue | 8.74% | -2.28% | 2.85% | -2.50% | 1.78% |
| Leverage | |||||
| Equity ratio | 64.04% | 41.30% | 56.93% | 30.74% | 58.53% |
| Debt / assets | 35.96% | 58.70% | 43.07% | 69.26% | 41.47% |
| Debt / equity | 0.56 | 1.42 | 0.76 | 2.25 | 0.71 |
| Interest coverage (EBIT) | -832.24 | 7.89 | 14.98 | -5.18 | 10.78 |
| Efficiency | |||||
| Asset turnover | 5.42 | 4.44 | 4.17 | 13.15 | 9.46 |
| Fixed assets / revenue | 3.09% | 11.58% | 10.81% | 4.84% | 4.40% |
| Receivables / revenue | 8.77% | 1.45% | 0.96% | 0.51% | 0.64% |
| DSO (days) | 32 | 5 | 4 | 2 | 2 |
Estimated value
0 PLN
Year: 2023
closed
Input data for 2023, which the model uses to compute the company's estimated value.
Scale of operations
Balance sheet
Debt
Indicators
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Sofimed Spółka z Ograniczoną Odpowiedzialnością w Likwidacji